Premium
Erythropoietin production in hepatocellular carcinoma cells associated with polycythemia: Immunohistochemical evidence
Author(s) -
Sakisaka Shotaro,
Watanabe Masahide,
Tateishi Hideo,
Harada Masaru,
Shakado Satoshi,
Mimura Yoshihiro,
Gondo Kazuhisa,
Yoshitake Masao,
Noguchi Kazunori,
Hino Teruko,
Nohno Ryuichi,
Majima Yasuo,
Hirai Kenji,
Sata Michio,
Yoshida Hiroshi,
Tanikawa Kyuichi
Publication year - 1993
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.1840180612
Subject(s) - hepatocellular carcinoma , erythropoietin , immunohistochemistry , medicine , cancer research , pathology , oncology
Patients with hepatocellular carcinoma sometimes have erythrocytosis and high plasma erythropoietin levels. However, previous studies have not revealed direct evidence that the carcinoma cells produce the erythropoietin. To address this question, we carried out light and electron microscopic immunohistochemical studies, using a human erythropoietin antibody to the liver in three male patients with hepatocellular carcinoma and erythrocytosis. α‐Fetoprotein localization was also examined in serial liver sections by light microscopic immunohistochemistry with an antibody to α‐fetoprotein. All three patients demonstrated high hemoglobin levels (16.7, 17.6 and 18.1 gm/dl) and high plasma erythropoietin levels (227, 266 and 280 mU/ml). In one patient the plasma erythropoietin level in the hepatic vein was significantly higher than that in the hepatic artery. The levels of plasma erythropoietin, as well as such tumor markers for hepatocellular carcinoma as serum α‐fetoprotein and plasma des‐γ‐carboxyprothrombin, were significantly reduced after treatment with an anticancer drug, cisplatin. Light microscopic immunohistochemistry showed that erythropoietin was definitely present in the cytoplasm of the hepatocellular carcinoma cells, but not in normal hepatocytes around the carcinoma lesion or in other nonparenchymal cells such as vascular endothelial cells and Kupffer cells. In electron microscopic immunohistochemistry, reaction products for erythropoietin were revealed in the cisternae of the endoplasmic reticulum in the carcinoma cells, suggesting the production of erythropoietin by these cells. Light microscopic immunohistochemistry showed that α‐fetoprotein was localized in the hepatocellular carcinoma cells that were erythropoietin positive in the serial sections. These findings indicated that hepatocellular carcinoma cells produced erythropoietin as well as α‐fetoprotein in these cases, leading to the complication of erythrocytosis. (HEPATOLOGY 1993;18:1357–1362.)